Location
Boston, MA
Holdings as of
6/30/2020
Date filed
8/14/2020
Form type
13F-HR
Num holdings
96
Total value ($000)
$1,674,146
Net value change ($000)
+460,039 (37.9%)
New positions
26
Sold out positions
15
Turnover %
38.8%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2020 Next filing: 11/16/2020 SEC filing

Snapshot: Change Analysis

Compared to Q1 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Horizon Therapeutics Public Ltd Co 46,167 NEW
TSLA 43,417 101.0%
SLQT 36,935 NEW
LAD 31,328 NEW
FND 29,545 460.3%
EHTH 24,766 NEW
SHOP 21,291 127.7%
ROST 20,747 NEW
EVERBRIDGE, INC. 18,365 172.7%
RH 18,189 NEW
Top Reduces (Value $000, Stocks/ETFs)
CI -33,878 -100.0%
FISV -26,837 -100.0%
VRTX -23,718 -79.8%
DOCU -18,936 -100.0%
UNH -15,020 -44.2%
AMZN -14,818 -28.1%
META -14,105 -100.0%
CRWD -10,763 -13.2%
SMPL -7,704 -100.0%
NVDA -7,604 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 483,675 (28.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type